新型示踪剂用于放射性核素显像评估心肌炎症
本文综述了非FDG放射性示踪剂在心肌炎症显像中的进展,聚焦心脏结节病、心肌炎和急性心肌梗死。FDG-PET虽为当前分子显像主要方法,但受生理性心肌摄取及多种疾病机制摄取倾向影响;靶向不同炎症免疫细胞和分子通路的新型示踪剂可提供独特见解,并可能提高疾病活动度定量、辅助免疫调节治疗指导与监测。
要点
- FDG-PET是当前心肌炎症分子显像的主要方法,但受生理性心肌摄取及多种疾病机制摄取倾向影响。
- 靶向不同炎症免疫细胞和分子通路的新型放射性示踪剂可可视化炎症心脏病发病机制中的核心机制。
- 新型示踪剂可能提高特异性,有助于疾病活动度定量及免疫调节治疗的指导与监测。
核心结论
- 靶向不同炎症免疫细胞和分子通路的新型放射性示踪剂可提供独特见解,可视化炎症心脏病发病机制的核心机制。
- 新型示踪剂可能提高特异性,有助于更好地定量疾病活动度,辅助免疫调节治疗的指导与监测。
研究设计与样本
- 本文为综述,旨在更新非FDG放射性示踪剂用于心肌炎症性疾病显像的进展,聚焦心脏结节病、心肌炎和急性心肌梗死。
主要发现
- FDG-PET是当前心肌炎症分子显像的主要方法,但受生理性心肌摄取及多种疾病机制摄取倾向影响,效果受限。
- 靶向不同炎症免疫细胞和分子通路的新型放射性示踪剂可提供独特见解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myocardial inflammation plays a central role in the pathophysiology of various cardiac diseases. While FDG-PET is currently the primary method for molecular imaging of myocardial inflammation, its effectiveness is hindered by physiological myocardial uptake as well as its propensity for uptake by multiple disease-specific mechanisms. Novel radiotracers targeting diverse inflammatory immune cells and molecular pathways may provide unique insight through the visualization of underlying mechanisms central to the pathogenesis of inflammatory cardiac diseases, offering opportunities for increased understanding of immunocardiology. Moreover, the potentially enhanced specificity may lead to better quantification of disease activity, aiding in the guidance and monitoring of immunomodulatory therapy. This review aims to provide an update on advancements in non-FDG radiotracers for imaging myocardial inflammatory diseases, with a focus on cardiac sarcoidosis, myocarditis, and acute myocardial infarction.
引用
- Lucinian YA, Martineau P, Abikhzer G, et al. Novel tracers to assess myocardial inflammation with radionuclide imaging. J Nucl Cardiol. 2024. PMID: 39069249. doi:10.1016/j.nuclcard.2024.102012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。